The U.S is struggling with the recent surge in daily new Covid-19 cases, and the FDA has been working hard to study the benefits of the third shot for immunocompromised patients. Fortunately, today the third shot has been approved for those who have been diagnosed with a compromised immune system.
Who qualifies for a third shot?
For now, the FDA has decided that a third shot is beneficial for those who underwent organ transplants, those who suffer from diseases and other severe health issues. The rest of the fully vaccinated individuals are not yet scheduled for a booster shot. All the clinical recommendations on who qualifies as an immunocompromised patient will be discussed today. The CDC and the Prevention’s Advisory Committee on Immunisation Practices will meet to draft the general recommendations.
The U.S is facing a new Covid-19 infection wave
As the country is experiencing a new wave, health experts are trying hard to protect as many people as possible. This is why the FDA determined that it is beneficial for those immunocompromised to receive a booster shot. This third booster shot could offer enough antibodies against the Delta variant. The FDA’s statement also mentions that all those immunocompromised should talk with their health providers about monoclonal antibody treatments and other options available to help with a Covid-19 diagnosis.
What treatments against the Covid-19 could immunocompromised people take?
According to the report, an authorised product can be used by people with a compromised immune system fighting a Covid-19 infection. The treatment is called REGEN-COV monoclonal antibody therapy, and it is used after Covid-19 exposure. The treatment uses monoclonal antibodies casirivimab and imdevimab that can help people fight off severe symptoms. The duration of the treatment is not the same for everyone, and only doctors can decide depending on the patient’s response.
